PMID

Data

Article Title

Organization

Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis.

Tsinghua University

Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the innate immune receptor NOD2.

University of Ljubljana

Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-amines.

University of Kansas

Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.

University of Ljubljana

Identification of Inhibitors of NOD1-Induced Nuclear Factor-żB Activation.

TBA

Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2.

University of Ljubljana

Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[

Glaxosmithkline

Modulation of the NOD-like receptors NOD1 and NOD2: A chemist's perspective.

University of Delaware

Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties.

University of Ljubljana

Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.

Chinese Academy of Medical Sciences and Peking Union Medical College

Modulation of aldose reductase inhibition by halogen bond tuning.

Academy of Sciences of The Czech Republic